We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advances in Bavarian Nordic’s Cancer Immunotherapy Platform

Product News   Nov 07, 2019

 
Advances in Bavarian Nordic’s Cancer Immunotherapy Platform
FURTHER INFORMATION
 
 
 

Related Product News

Antibody Enters Clinical Trial for Treatment of B Cell Acute Lymphoblastic Leukemia

Product News

IONTAS has been informed that International Biotechnology Center (IBC) Generium has received approval from the Russian Health Authorities to initiate clinical trials with its CD3/CD19 bispecific antibody for the treatment of B Cell Acute Lymphoblastic Leukemia (ALL).

READ MORE

Pre-approval Access Collaboration for Novel Cancer Therapeutic

Product News

Onconova and Inceptua Medicines Access have announced that they have entered into a collaboration to make available intravenous rigosertib via a Pre-approval Access Program in selected countries around the world.

READ MORE

Inceptua and Bendalis Enter Into Oncology Medicine Supply Agreement for Clinical Trials

Product News

The global pharmaceutical company and service partner Inceptua and Bendalis have announced the signing of an exclusive clinical trial supply agreement for oncology generics.

READ MORE

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE